Treating Severe Chronic Epstein-Barr Virus (EBV) Infection With EBV Specific Cytotoxic T Lymphocytes (CTLs)

Clinical trial NCT00058591 · COMPLETED

Trial details

NCT number: NCT00058591
Sponsor: Baylor College of Medicine
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Epstein-Barr Virus Infections

Start date: 2000-01-01
Primary completion: 2008-12-01
Enrollment: 13

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.